In addition, the identification of the presence or absence of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor (HER2) among breast cancers has paved the way for targeted and tailored therapy, thus contributing to improvements in breast cancer outcomes and decreases in breast cancer mortality. The gene discussed is ERBB2; the disease is breast carcinoma.